These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 3501125

  • 21. New developments in Kawasaki disease.
    Leung DY.
    Curr Opin Rheumatol; 1991 Feb; 3(1):46-55. PubMed ID: 1710476
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Development of Kawasaki disease and the initial infection by EB virus].
    Kikuta H, Mizuno F, Osato T, Konno M, Ishikawa N, Nanbu H, Anakura M, Oka Y, Matsumoto S, Noro S.
    Nihon Rinsho; 1983 Sep; 41(9):2069-74. PubMed ID: 6319775
    [No Abstract] [Full Text] [Related]

  • 24. [Enumeration of T cell subsets in patients with MCLS using monoclonal antibodies].
    Seto S, Miyake T, Hirao T.
    Arerugi; 1983 Sep; 32(9):970-8. PubMed ID: 6607721
    [No Abstract] [Full Text] [Related]

  • 25. [Autoantibodies in patients with mucocutaneous lymph node syndrome (Kawasaki disease)].
    Saji T, Umezawa T, Hashiguchi R, Matsuo N.
    Arerugi; 1983 Dec; 32(12):1129-33. PubMed ID: 6678147
    [No Abstract] [Full Text] [Related]

  • 26. Kawasaki syndrome. Further etiologic pursuits--not trivial.
    Johnson KM.
    Prog Clin Biol Res; 1987 Dec; 250():485-91. PubMed ID: 2827181
    [No Abstract] [Full Text] [Related]

  • 27. [Kawasaki disease: its incidence in our medium].
    González Pascual E, Jiménez González R.
    An Esp Pediatr; 1999 Aug; 51(2):111-9. PubMed ID: 10495495
    [No Abstract] [Full Text] [Related]

  • 28. Superantigens: a brief review with special emphasis on dermatologic diseases.
    Solanki LS, Srivastava N, Singh S.
    Dermatol Online J; 2008 Feb 28; 14(2):3. PubMed ID: 18700106
    [No Abstract] [Full Text] [Related]

  • 29. [New therapeutic aspects in Kawasaki syndrome and personal experiences].
    Neudorf U.
    Infusionsther Transfusionsmed; 1993 Apr 28; 20 Suppl 1():137-9. PubMed ID: 8499743
    [Abstract] [Full Text] [Related]

  • 30. The role of T cells in Kawasaki disease.
    de Inocencio J, Hirsch R.
    Crit Rev Immunol; 1995 Apr 28; 15(3-4):349-57. PubMed ID: 8834455
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease.
    Burns JC, Geha RS, Newburger JW, Huang AS, Leung DY.
    Prog Clin Biol Res; 1987 Apr 28; 250():125-30. PubMed ID: 2447591
    [No Abstract] [Full Text] [Related]

  • 34. [Mucocutaneous lymph node syndrome (Kawasaki disease). Presentation of 3 cases].
    Hernández Lorca A, Bentiez Rubio MR, García Santiago M, Hernández Delgado J, García Suárez E, González Mediero I, Silgo Pujalte M, García Pérez J.
    An Esp Pediatr; 1983 Jul 28; 19(1):59-64. PubMed ID: 6638713
    [Abstract] [Full Text] [Related]

  • 35. Soluble CD2 levels in serum during acute Kawasaki disease and infectious mononucleosis.
    Furukawa S, Matsubara T, Obara T, Okumura K, Yabuta K.
    J Infect Dis; 1993 Mar 28; 167(3):778-9. PubMed ID: 8095062
    [No Abstract] [Full Text] [Related]

  • 36. [Mucocutaneous lymph node syndrome of Kawasaki disease. Presentation of a case].
    Zulaica D, Alonso M, Ortega J, Pérez Yarza E, Damiano A.
    Rev Clin Esp; 1981 Nov 30; 163(4):265-7. PubMed ID: 7335936
    [No Abstract] [Full Text] [Related]

  • 37. Immunologic aspects of Kawasaki syndrome.
    Leung DY.
    J Rheumatol Suppl; 1990 Sep 30; 24():15-8. PubMed ID: 1700120
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.